Skip to content

Author

M. Lantinga

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Porto-sinusoidal vascular disorder-type lesions in patients with early fibrotic stages of metabolic dysfunction-associated steatotic liver disease.

BACKGROUND AND OBJECTIVE Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rising cause of chronic liver disease. Liver stiffness measurement (LSM) to assess disease stage is gaining popularity but can demonstrate heterogeneous results in clinical practice. Moreover, portal hypertension may develop...

Diederick J. van Doorn, L. Schoenmakers, S. de Jager et al. · 0 citations
Review Open access Oct 2026

Antibiotic Stewardship in Cirrhosis: Current Recommendations and Clinical Challenges

ABSTRACT Bacterial infections are a major cause of mortality in cirrhosis, with antibiotic prophylaxis and empirical treatment embedded in international guidelines. However, the prevalence of multidrug‐resistant organisms and the epidemiology of infections have shifted considerably in recent decades. This review critic...

Solaiman Ezzafzafi, K. Bot, L. Bernts et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.